ArticleContemporary clinical trials2019

A pragmatic, adaptive clinical trial design for a rare disease: The FOcal Cerebral Arteriopathy Steroid (FOCAS) trial.

Yeonhee Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.